https://es.marketscreener.com/cotizacion/accion/ASTELLAS-PHARMA-INC-6491262/noticia/Astellas-Pharma-inicia-en-Jap-n-los-estudios-cl-nicos-de-fase-3-con-fezolinetant-para-el-SMV-asoci-46092920/?utm_source=telegram&utm_medium=social&utm_campaign=share